ERAS-Gyneco: ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.

Sponsor
Ospedale Regina Montis Regalis (Other)
Overall Status
Recruiting
CT.gov ID
NCT04063072
Collaborator
Martini Hospital, Turin, Italy (Other), Azienda Ospedaliera Città della Salute e della Scienza di Torino (Other), Ministry of Health, Italy (Other), Regione Piemonte (Other)
1,800
1
2
26
69.3

Study Details

Study Description

Brief Summary

The study assesses the impact on quality of care of implementing the ERAS (Enhanced Recovery After Surgery) protocol for hysterectomy of benign or malignant tumors of the uterus in the network of public hospitals in the Regione Piemonte (North-West Italy). Every hospital is a cluster entering the study treating patients according to its current clinical practice. On the basis of a randomized order, each hospital switches from current clinical practice to the adoption of the ERAS protocol.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ERAS protocol
N/A

Detailed Description

ERAS (Enhanced Recovery After Surgery) protocol is a multimodal perioperative care pathways designed to achieve early recovery after surgical procedures by maintaining preoperative organ function and reducing the profound stress response following surgery. Even if efficacy and safety of ERAS protocol in gynaecological surgery is well-established in the literature, its implementation is limited to few selected centres in Piemonte. The aim of the study is to extend the implementation of the ERAS protocol to whole regional network of hospitals. Specific objectives are to estimate its impact on different dimensions of quality of care, including length of stay, complications and patient satisfaction, and to identify possible barriers or facilitating factors.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1800 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
A stepped-wedge cluster randomized clinical trial. Each center starts as control group (usual care) and switch to experimental group (ERAS protocol implementation) according to a randomized order.A stepped-wedge cluster randomized clinical trial. Each center starts as control group (usual care) and switch to experimental group (ERAS protocol implementation) according to a randomized order.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy of Benign or Malignant Tumors of the Uterus. A Stepped-wedge Cluster Randomized Clinical Trial.
Actual Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Jul 31, 2021
Anticipated Study Completion Date :
Oct 31, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual care

Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to current hospital clinical practice.

Experimental: ERAS protocol

Perioperative care for hysterectomy of benign or malignant tumors of the uterus is managed according to ERAS protocol.

Procedure: ERAS protocol
In gynecological surgery, the ERAS protocol involves an accurate interview with the patient in the preoperative phase aimed at smoking and alcohol cessation, the reduction of preoperative fasting, the omission of intestinal preparation, the prophylaxis of thromboembolism, a correct antibiotic prophylaxis, the prevention of intraoperative hypothermia, prevention of volume overload, prevention of postoperative nausea and vomiting, very limited use of the nasogastric tube, early removal of the urinary catheter, multimodal analgesia to minimize opiate consumption, early postoperative mobilization and early post-operative feeding, to promote rapid recovery of gastro-intestinal functions.
Other Names:
  • ERAS (Enhanced Recovery After Surgery) protocol
  • Outcome Measures

    Primary Outcome Measures

    1. Length of stay [12 days after admission]

      Mean length of stay calculated as difference between date of discharge and date of admission of the hospitalization for surgery, excluding length of stay >12 days (98th percentile of the expected distribution).

    Secondary Outcome Measures

    1. Length of stay >12 days [30 days after admission]

      Rate of patients with a length of stay >12 days

    2. Recovery after surgery [24 hours after surgery]

      Score of quality of recovery at 24 hours after surgery, assessed with the questionnaire Quality of Recovery (QoR-15), a 15-items instrument, with responses recorded on a 11-point Likert-type scale form 0 (worst scenario) to 10 (best scenario) and an overall score ranging from 0 (poor recovery) to 150 (excellent recovery). A visual analogue scale (VAS), ranging from 0 (worst imaginable health state) to 10 (worst imaginable health state) is also supplied as summary evaluation.

    3. Complications [30 days after discharge]

      Rate of surgical and medical complication after surgery For surgical complications: Comprehensive Complication Index

    4. Transfer to intensive care unit [30 days after surgery]

      Rate of transfers to intensive care unit after surgery

    5. Emergency visits after discharge [30 days after discharge]

      Rate of emergency visit in the first month after discharge

    6. Hospital admissions after discharge [30 days after discharge]

      Rate of new admissions in the first month after discharge

    7. Reintervention [30 days after surgery]

      Rate of reintervention in the first month after surgery, excluding planned interventions

    8. Patients' satisfaction [15 days after discharge]

      Score of patients' satisfaction measured 2 weeks after discharge, assessed with the questionnaire Surgical Satisfaction Questionnaire (SSQ8) supplied by telephone. SSQ8 is a 8-items instrument, with responses recorded on a 5-point Likert-type scale from 0 (worst scenario) to 4 (best scenario) and an overall score ranging from 0 (very unsatisfied) to 32 (very satisfied).

    9. Healthcare costs [30 days after discharge]

      Mean healthcare costs from pre admission visit to 30 days after discharge

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All the hospital wards within the Piemonte Region performing hysterectomy.

    • All the patients receiving an elective hysterectomy for benign or malignant tumors of the uterus.

    Exclusion Criteria:
    • Hospital wards performing less than 20 expected cases per year

    • Emergency hysterectomy

    • Hysterectomy for pelvic floor disorders

    • High severity cases not allowing ERAS protocol implementation (i.e. American Society of Anesthesiologists score: ASA V).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ospedale Regina Montis Regalis Mondovì Italy

    Sponsors and Collaborators

    • Ospedale Regina Montis Regalis
    • Martini Hospital, Turin, Italy
    • Azienda Ospedaliera Città della Salute e della Scienza di Torino
    • Ministry of Health, Italy
    • Regione Piemonte

    Investigators

    • Study Chair: Giovannino Ciccone, MD, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr. Andrea Puppo, Gynecologists, Ospedale Regina Montis Regalis
    ClinicalTrials.gov Identifier:
    NCT04063072
    Other Study ID Numbers:
    • ERAS-Gyneco-Piemonte
    First Posted:
    Aug 21, 2019
    Last Update Posted:
    Jun 2, 2021
    Last Verified:
    Jun 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Dr. Andrea Puppo, Gynecologists, Ospedale Regina Montis Regalis
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 2, 2021